NCT05069012View on ClinicalTrials.gov

Intrathecal Morphine for Cesarean Delivery

PHASE4CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

November 15, 2021

Primary Completion Date

July 23, 2022

Study Completion Date

July 23, 2022

Conditions
Postoperative Pain
Interventions
DRUG

Morphine Sulfate

Morphine is administered to provide pain relief after cesarean delivery; this is an assessment of the dose-response as measured by the duration of pain relief

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
lead

Beth Israel Deaconess Medical Center

OTHER

NCT05069012 - Intrathecal Morphine for Cesarean Delivery | Biotech Hunter | Biotech Hunter